azithromycin stada mixtúruduft, dreifa 40 mg/ml
stada arzneimittel ag - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml
teysuno
nordic group b.v. - tegafúri, gimeracil, oteracil - magaæxli - Æxlishemjandi lyf - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
orfiril magasýruþolin tafla 150 mg
desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 150 mg
orfiril magasýruþolin tafla 600 mg
desitin arzneimittel gmbh - natrii valproas - magasýruþolin tafla - 600 mg
orfiril mixtúra, lausn 60 mg/ml
desitin arzneimittel gmbh - natrii valproas - mixtúra, lausn - 60 mg/ml
zitromax stofn fyrir innrennslisþykkni, lausn 500 mg
pfizer aps - azithromycinum díhýdrat - stofn fyrir innrennslisþykkni, lausn - 500 mg
escitalopram bluefish filmuhúðuð tafla 5 mg
bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 5 mg
escitalopram bluefish filmuhúðuð tafla 10 mg
bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 10 mg
escitalopram bluefish filmuhúðuð tafla 15 mg
bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 15 mg
xylocain adrenalin stungulyf, lausn 10 mg/ml+5 míkróg/ml
aspen pharma trading limited - lidocainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 10 mg/ml+5 míkróg/ml